News Summary

FACIT and the Ontario Bioscience Innovation Organization (OBIO) have announced the first cohort of the Women’s Synergistic Entrepreneurship and Economic Development (WeSEED) program. This initiative is designed to support women-led life sciences startups in advancing healthcare and Ontario-based intellectual property. The program provides business training, advisory resources, networks, and venture funding, focusing on commercialization, fundraising, and technical and IP viability. The inaugural cohort includes companies such as A.I. VALI, Genetics Adviser, AiimSense, Asima Health, and Cura Therapeutics, with various startups receiving investments from FACIT’s Compass Rose Oncology Fund. The program aims to improve the equity, representation, and positioning of women STEM leaders in Ontario’s healthcare innovation sector.